logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

China Merchants Securities: Non-executive director Liu Hui retires and resigns due to reaching retirement age.

date
21/11/2025
On November 21, China Merchants Securities announced that non-executive director Liu Hui applied to resign from his positions due to retirement age. His resignation will take effect upon delivery of his resignation report to the company's board of directors.
Latest
2 m ago
Guosen Securities International: Maintains "buy" rating on China Datang Corporation Renewable Power (01798.HK) Q3 performance under pressure but significant improvement in cash flow.
2 m ago
Ministry of Finance: Include savings national bonds in the scope of individual pension products.
2 m ago
Huilong Technology (01860.HK) reported a Q3 revenue of 532 million US dollars, with AI and machine learning algorithms supporting Mintegral's growth space.
2 m ago
Two departments: conducting comprehensive evaluations of H-share accounting firms every year. Those no longer meeting the basic requirements will have their recommendations revoked.
3 m ago
Wo Wu Biological: The supplementary application for clinical trials of swine grass pollen prick fluid medicine has been approved.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.